research group | Q1241025 |
Q51896616 | Cataract classification using serial examinations in the age-related eye disease study: age-related eye disease study report no. 24. |
Q35762167 | Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21 |
Q33502975 | Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. |
Q35554026 | Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34 |
Q34652041 | Cognitive impairment in the Age-Related Eye Disease Study: AREDS report no. 16. |
Q34654493 | Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial |
Q34666874 | Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. |
Q34655531 | National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10 |
Q34164826 | Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. |
Q34620551 | No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 |
Q34655518 | Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. |
Q34084938 | Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5. |
Q34522738 | Summary results and recommendations from the age-related eye disease study |
Q39280720 | Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. |
Q51210154 | Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33. |
Q34655539 | The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. |
Q43796210 | The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. |
Q34651797 | The Age-Related Eye Disease Study: a clinical trial of zinc and antioxidants--Age-Related Eye Disease Study Report No. 2 |
Q35798037 | The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37 |
Q59446740 | The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study |
Q36076822 | The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. |
Q34623556 | The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7. |
Q33613367 | The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23 |
Q34493282 | Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27 |
Q37421203 | {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study |
Search more.